TPWA
RMD icon

Twin Peaks Wealth Advisors’s ResMed RMD Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.9K Buy
+365
New +$91K 0.02% 322
2025
Q3 		– Sell
-317
Closed -$89.7K – 1673
2025
Q2 		$89.7K Buy
+317
New +$75.6K 0.03% 245

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Twin Peaks Wealth Advisors's RMD Position: Q1 2026 in Review

Twin Peaks Wealth Advisors opened a new position in ResMed (RMD) in Q1 2026: 365 shares worth $81.9K. The stake represents 0.02% of the portfolio and ranks #322 among its holdings. This is a return to the name: Twin Peaks Wealth Advisors previously reported a position in RMD as recently as Q2 2025.

Twin Peaks Wealth Advisors first reported a position in RMD in Q2 2025 and has held it in 2 quarters since. The position peaked at $89.7K in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Twin Peaks Wealth Advisors held 365 shares of ResMed worth $81.9K as of Q1 2026.
  • ResMed was a new Twin Peaks Wealth Advisors position in Q1 2026.
  • ResMed made up 0.02% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #322 holding.
  • Twin Peaks Wealth Advisors first reported a position in ResMed in Q2 2025 and has held it in 2 quarters since.
  • Twin Peaks Wealth Advisors's ResMed position peaked at $89.7K in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.